首页> 美国卫生研究院文献>International Journal of Molecular Sciences >MgSi—Co-Substituted Hydroxyapatite/Alginate Composite Beads Loaded with Raloxifene for Potential Use in Bone Tissue Regeneration
【2h】

MgSi—Co-Substituted Hydroxyapatite/Alginate Composite Beads Loaded with Raloxifene for Potential Use in Bone Tissue Regeneration

机译:MgSi-Co-取代的羟基磷灰石/藻酸盐复合珠装载雷洛昔芬用于潜在在骨组织再生中使用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteoporosis is a worldwide chronic disease characterized by increasing bone fragility and fracture likelihood. In the treatment of bone defects, materials based on calcium phosphates (CaPs) are used due to their high resemblance to bone mineral, their non-toxicity, and their affinity to ionic modifications and increasing osteogenic properties. Moreover, CaPs, especially hydroxyapatite (HA), can be successfully used as a vehicle for local drug delivery. Therefore, the aim of this work was to fabricate hydroxyapatite-based composite beads for potential use as local carriers for raloxifene. HA powder, modified with magnesium and silicon ions (Mg,Si-HA) (both of which play beneficial roles in bone formation), was used to prepare composite beads. As an organic matrix, sodium alginate with chondroitin sulphate and/or keratin was applied. Cross-linking of beads containing raloxifene hydrochloride (RAL) was carried out with Mg ions in order to additionally increase the concentration of this element on the material surface. The morphology and porosity of three different types of beads obtained in this work were characterized by scanning electron microscopy (SEM) and mercury intrusion porosimetry, respectively. The Mg and Si released from the Mg,Si-HA powder and from the beads were measured by inductively coupled plasma optical emission spectrometry (ICP-OES). In vitro RAL release profiles were investigated for 12 weeks and studied using UV/Vis spectroscopy. The beads were also subjected to in vitro biological tests on osteoblast and osteosarcoma cell lines. All the obtained beads revealed a spherical shape with a rough, porous surface. The beads based on chondroitin sulphate and keratin (CS/KER-RAL) with the lowest porosity resulted in the highest resistance to crushing. Results revealed that these beads possessed the most sustained drug release and no burst release effect. Based on the results, it was possible to select the optimal bead composition, consisting of a mixture of chondroitin sulphate and keratin.
机译:骨质疏松症是全球慢性疾病,其特征在于增加骨脆性和骨折似然性。在治疗骨缺陷时,由于其与骨矿物质,它们的非毒性高的相似性和对离子修饰的亲和力以及增加成骨改性,因此使用基于磷酸钙(帽)的材料。此外,盖子,尤其是羟基磷灰石(HA),可以成功地用作当地药物递送的载体。因此,这项工作的目的是制造基于羟基磷灰石的复合珠,以潜在用作雷洛昔芬的局部载体。使用镁和硅离子(Mg,Si-Ha)(两者在骨形成中发挥有益作用)的HA粉末制备复合珠。作为有机基质,施用硫酸软骨素和/或角蛋白的藻酸钠。用Mg离子进行含有Raloxifen盐盐酸盐(RAL)的交联珠子(RAL),以另外增加材料表面上该元素的浓度。通过扫描电子显微镜(SEM)和汞侵入孔孢子液,其特征在于该作品中获得的三种不同类型珠粒的形态和孔隙率。通过电感耦合等离子体光发射光谱法(ICP-OES)测量从Mg,Si-Ha粉末和珠子释放的Mg和Si。研究了体外释放型材12周并使用UV / Vis光谱研究。在成骨细胞和骨肉瘤细胞系上也经过体外生物试验进行珠子。所有获得的珠子都透露了具有粗糙的多孔表面的球形形状。基于软骨素硫酸盐和角蛋白(Cs / Ker-RAL)的珠子,具有最低孔隙率导致的最高抗性抗性。结果表明,这些珠子具有最持续的药物释放,没有爆发释放效果。基于结果,可以选择由软骨素和角蛋白的混合物组成的最佳珠组合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号